BOSTON, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Ampersand Biomedicines, a multi-product platform company developing smarter medicines that act specifically at the site of disease and nowhere else, today ...

NEW YORK--(BUSINESS WIRE)--Bristol Myers Squibb Company (NYSE:BMY) announced today that Elizabeth Mily has been appointed Executive Vice President, Strategy & Business Development, effective March ...